LG 101506: Reliable RXR Modulator for Advanced Nuclear Receptor Research

Executive Summary: LG 101506 is a chemically defined, small molecule RXR modulator with 98% purity, intended for research use in nuclear receptor and immune checkpoint studies (APExBIO). It displays robust solubility (42.05 mg/ml in DMSO, 21.03 mg/ml in ethanol) and is stable when stored at -20°C. RXR modulation by LG 101506 enables the study of RXR signaling impact on metabolism and immune regulation (Zhang et al. 2022). The compound facilitates precise dissection of RXR’s role in PD-L1 expression, relevant in cancer immunotherapy. APExBIO provides LG 101506 (SKU B7414) for non-clinical, laboratory-based investigations only.

Biological Rationale

Retinoid X Receptors (RXRs) are nuclear receptors that regulate gene transcription in response to retinoid ligands. RXRs form heterodimers with other nuclear receptors—such as PPARs, LXRs, and FXRs—modulating pathways involved in lipid metabolism, glucose homeostasis, and cell proliferation (Zhang et al., 2022). Aberrant RXR signaling is implicated in metabolic disorders and cancer progression. RXR also intersects immune checkpoint regulation, influencing PD-L1 expression and immune evasion in tumor microenvironments (Zhang et al., 2022).

Mechanism of Action of LG 101506

LG 101506 is a small molecule RXR modulator with the chemical structure (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid. It binds to the ligand-binding domain of RXR, altering receptor conformation. This modulation affects dimerization with partner receptors (e.g., PPARs), driving changes in gene expression related to metabolism and immune function. In cellular models, RXR modulators can impact expression of immune checkpoint proteins such as PD-L1, linking RXR activity to immunomodulatory pathways (Zhang et al., 2022). The compound’s high purity (98%) and solubility facilitate reproducible dosing in both in vitro and ex vivo assays (APExBIO).

Evidence & Benchmarks

• RXR signaling regulates gene networks controlling lipid and glucose metabolism (Zhang et al., 2022, https://doi.org/10.1038/s41418-022-01012-0).
• Modulation of RXR can alter the transcription of immune checkpoint molecules, including PD-L1 (Zhang et al., 2022, https://doi.org/10.1038/s41418-022-01012-0).
• Loss of RBMS1 in tumor cells decreases PD-L1 levels, enhancing anti-tumor immunity in triple-negative breast cancer models (Zhang et al., 2022, https://doi.org/10.1038/s41418-022-01012-0).
• LG 101506 offers solubility up to 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol, supporting diverse assay formats (APExBIO).
• High compound stability is maintained during shipment on blue ice (small molecule) or dry ice (modified nucleotides) (APExBIO).

For an expanded discussion of LG 101506’s role in immune checkpoint regulation, see this article, which this dossier updates with new evidence from triple-negative breast cancer models.

Applications, Limits & Misconceptions

LG 101506 is used in RXR signaling pathway research, nuclear receptor signaling, and metabolism regulation. It supports studies on immune checkpoint biology, especially PD-L1 expression in cancer models. The compound is not intended for diagnostic or therapeutic applications. It should be used under controlled laboratory conditions.

Common Pitfalls or Misconceptions

• LG 101506 is not suitable for clinical or diagnostic use; it is for research only (APExBIO).
• Long-term storage of dissolved solutions (>1 week at -20°C) may result in degradation; freshly prepare solutions for each experiment.
• Not all cell types respond identically to RXR modulation; results may vary by model system.
• LG 101506 does not directly inhibit PD-1/PD-L1 binding; it modulates upstream gene expression.
• Use of LG 101506 outside recommended solvents (DMSO, ethanol) may result in poor solubility or precipitation.

For robust cell-based assay guidance, see this scenario-driven article, which the present dossier clarifies by providing detailed physicochemical parameters and stability notes.

Workflow Integration & Parameters

Recommended storage is at -20°C in a desiccated environment. Solubility is optimal at 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol. Prepare solutions immediately prior to use for maximum activity. LG 101506 is compatible with cell viability, proliferation, and cytotoxicity assays. For experimental design and Q&A on deploying LG 101506 in nuclear receptor and immune checkpoint studies, refer to this resource, which this dossier extends by integrating new cancer immunity data points.

Conclusion & Outlook

LG 101506 (SKU B7414) from APExBIO is a chemically robust, high-purity RXR modulator supporting advanced research in metabolism, nuclear receptor biology, and immune checkpoint regulation. Recent studies highlight the importance of RXR modulation for understanding immune evasion in cancer, particularly via PD-L1 regulation (Zhang et al., 2022). Ongoing research may further clarify RXR’s role in disease models, supporting the development of novel combinatorial therapeutic strategies. For full product details and ordering, visit the LG 101506 product page.